title: Reply: To PMID 23300053.
authors.forename: Arne
authors.initials: A
authors.lastname: Schäfer
authors.forename: Michael R
authors.initials: MR
authors.lastname: Kraus
authors.forename: Michael
authors.initials: M
authors.lastname: Scheurlen
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000209:etiology* / Q000503:physiopathology*; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin